Vrp15 Sep 2016 19:41
Guys, i believe the sp will tread water around these levels till the commencement of the new phase along with the others that are planned per notified on previous RNS's. According to the note as posted below this will happen H
2 2016, so anytime between now and the new year. We have a compound that is clearly working backed by A listers, i believe we will see significant value if lsted on nasdaq along with the publishing of results. The cf aspect will create big value also if sucessful....so personally i am pretty confident here in my investment and i am prepared to wait for this to come good....:)
According to analyst Jaime Constable at N+1 Singer predicts RPL554 could be in a position to commence Phase III trials by the end of 2018 if development goes according to plan. "We remain upbeat and look forward to the commencement of Phase IIb trials in H2 2016" said constable.